Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H2B clustered histone 19, pseudogene (H2BC19P), is classified as a **pseudogene** in the human genome, mapping to chromosome 1[1][3][5]. Although its sequence is related to the histone H2B family, which encodes proteins critical for the nucleosome structure of chromatin, H2BC19P does not produce a functional protein product in humans[1][2][4][5]. Instead, it represents a non-coding genomic locus that arose via pseudogenization of ancestral histone genes and remains present in the human genome with no demonstrated biological function or direct involvement in human disease or therapeutic targeting. In other species like cat, pig, horse, and cattle, orthologous loci are functional protein-coding histone genes, but the human H2BC19P is explicitly defined as a pseudogene and is not an actionable target for drugs or diagnostics[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H2B clustered histone 19, pseudogene (H2BC19P).